Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Arlington
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Arlington, TX

Studies commonly pay $75 to $4,500 per completed study

1,866 clinical trials are currently recruiting participants within 30 miles of Arlington. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,866studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Arlington right now

Top 25 of 1,866 recruiting studies, sorted by proximity — each links to its official registry page

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Prostate Cancer, Prostate Adenocarcinoma Phase 2 Interventional 90 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (19.4 mi) · Sponsor: University of Chicago
See eligibility & contact on ClinicalTrials.gov (NCT05726292)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Cook Children's Medical Center — Fort Worth, Texas (11.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Locally Advanced Solid Tumor, Metastatic Solid Tumor Phase 1 Interventional 30 participants sought
Texas Oncology — Dallas, Texas (19.4 mi) · Sponsor: Acepodia Biotech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06415487)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Texas Oncology DFW — Dallas, Texas (19.4 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Triple Negative Breast Cancer, HER2-negative Breast Cancer Phase 1 Interventional 96 participants sought
Dren Investigational Site — Dallas, Texas (19.4 mi) · Sponsor: Dren Bio
See eligibility & contact on ClinicalTrials.gov (NCT06999187)

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Niemann-Pick Type C Disease, GM1 Gangliosidosis Phase 3 Interventional 147 participants sought
Children's Medical Center Dallas — Dallas, Texas (19.4 mi) · Sponsor: Azafaros B.V.
See eligibility & contact on ClinicalTrials.gov (NCT07054515)

Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity

Physical Inactivity, Phosphate Overload N/A Interventional 124 participants sought
University of Texas Southwestern — Dallas, Texas (19.4 mi) · Sponsor: University of Texas Southwestern Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT05147909)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
US Renal Care — Waxahachie, Texas (27.0 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
UT Southwestern Medical Center ( Site 0190) — Dallas, Texas (19.4 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Acute Ischemic Stroke N/A Interventional 408 participants sought
Baylor University Medical Center — Dallas, Texas (19.4 mi) · Sponsor: Amrou Sarraj
See eligibility & contact on ClinicalTrials.gov (NCT07115940)

Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

Cancer N/A Observational 10,000 participants sought
UT Southwestern Medical Centre — Dallas, Texas (19.4 mi) · Sponsor: University of Texas Southwestern Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT03617237)

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Large Cell Lymphoma, Diffuse, Relapsed Cancer Phase 2 Interventional 35 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (19.4 mi) · Sponsor: Dipenkumar Modi
See eligibility & contact on ClinicalTrials.gov (NCT05852717)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Dallas, Texas (19.4 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Solid Tumors Phase 2 Interventional 170 participants sought
Texas Oncology-Bedford — Bedford, Texas (10.0 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07415031)

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

Obesity Phase 3 Interventional 600 participants sought
North Texas Endocrine Center — Dallas, Texas (19.4 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT07503210)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
UT Southwestern/Simmons Cancer Center-Fort Worth — Fort Worth, Texas (11.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

Overactive Bladder (OAB), Urinary Urgency N/A Interventional 596 participants sought
UT Southwestern Medical Center — Dallas, Texas (19.4 mi) · Sponsor: Medstar Health Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06797245)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Dallas, Texas (19.4 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Complex Regional Pain Syndrome Type I Phase 3 Interventional 270 participants sought
Ambros Clinical Trial Site — Fort Worth, Texas (11.5 mi) · Sponsor: Ambros Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07210515)
Actively enrolling

Studies you may be able to join near Arlington

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Arlington

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Texas Clinical Research Institute

★ 4.6
1009 Magnolia St, Arlington, TX 76012
(817) 471-1070
"Very professional yet down to earth staff gave me an informative consultation. Thank you."
— Elizabeth Cortez, 5★

Arlington Research Center

711 E Lamar Blvd #200, Arlington, TX 76011
(817) 795-7546

DM Clinical Research- Irving

★ 4.3
Medical Office Building II, 2021 N MacArthur Blvd Ste 450, Irving, TX 75061
(945) 298-0007
"Great Clinical Place to pretesapate! Love the Team very nice caring people there."
— Janie Torres, 5★

North Hills Medical Research

★ 5.0
4351 Booth Calloway Rd #304, North Richland Hills, TX 76180
(817) 595-3399
"I have done several studies at this location. They are very polite and take the time to explain all the details. Hector,Steven,Claudia and Elizabeth…"
— Teresa R, 5★

North Texas Clinical Trials

★ 4.5
1650 W Rosedale St Ste 300, Fort Worth, TX 76104
(817) 744-8844
"I think this organization is doing important and valuable work with clinical trials, and I’ve appreciated being part of the study I started in April.…"
— Kristine Martinez, 2★

Evidentis Clinical Research

★ 5.0
617 Travis Ave, Fort Worth, TX 76104
(682) 651-1112
"An incredibly professional and responsive team. They make you feel genuinely cared for as a patient, balancing great hospitality with top-tier scient…"
— Daniela Polit, 5★

Helios Clinical Research - Fort Worth

★ 1.0
1307 8th Ave, Fort Worth, TX 76104
(817) 348-0228
"Most unprofessional medical establishment. Specifically Clinical Research Female - Erin Mcleod who works under Dr. Cynthia Robbins.<br><br>After spen…"
— jenna joy, 1★

Fortrea Clinical Research Unit

★ 3.4
1341 W Mockingbird Ln, Dallas, TX 75247
"While some staff are a little rough around the edges, I really love how they are transparent about things! You ask questions, you will get answers in…"
— Robert Hubbard, 5★

Rcts Inc

★ 4.2
3207 Esters Rd, Irving, TX 75062
(972) 871-7578
"They are very well-organized. Friendly staff and very quick which of the businesses were more like that"
— Cammille Jones, 5★

Clinical trials in Arlington: what's recruiting

The Arlington area currently has 1,866 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Arlington, the most active research areas are:

  • Cancer & Oncology13 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney2 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Arlington, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Arlington

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Arlington participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Arlington?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Arlington safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Arlington, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Arlington?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Arlington.

Paid clinical trials near Arlington

Other metros within reach

Grand Prairie, TX1,947 Irving, TX1,979 Fort Worth, TX609 Dallas, TX1,864 Plano, TX1,817 Denton, TX379 Garland, TX1,826 Mesquite, TX1,767

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Arlington Chronic Kidney Disease (HealthMatch) in Arlington Bladder Issues Due To Spinal Cord Injury in Arlington All conditions

More of TX

Houston3,068 Pasadena3,007 Irving1,979 Grand Prairie1,947 Dallas1,864 Garland1,826 Plano1,817 Frisco1,816 Mesquite1,767 San Antonio1,023 Austin736

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts